NIH-Funded Breakthrough Shrinks CRISPR for Precision In-Vivo Delivery
An NIH-funded research team has engineered a significantly smaller and more stable CRISPR enzyme, Al3Cas12f RKK, enablin...
Read More →An NIH-funded research team has engineered a significantly smaller and more stable CRISPR enzyme, Al3Cas12f RKK, enablin...
Read More →The FDA has approved donanemab, a first-in-class monoclonal antibody for early-stage Alzheimer's disease, following the ...
Read More →The FDA approved gedatolisib (Revtorpyk) on July 14, 2026, as the first comprehensive PI3K/AKT/mTOR pathway inhibitor fo...
Read More →The Phase III FIND-CKD trial reveals that finerenone significantly slows kidney function decline and reduces cardiovascu...
Read More →A groundbreaking real-world study presented at the 2026 Alzheimer’s Association International Conference reveals that ...
Read More →Recent Phase II clinical trial data reveal unprecedented efficacy for personalized mRNA cancer vaccines in treating reca...
Read More →CAR-T cell therapy has achieved tremendous success in 2026 clinical trials, inducing prolonged remission in patients wit...
Read More →Researchers have successfully utilized a novel nanotechnology strategy to reverse Alzheimer’s disease symptoms in muri...
Read More →A groundbreaking clinical trial by the Dana-Farber Cancer Institute reveals that adding a vitamin D analog to standard c...
Read More →Mayo Clinic researchers have achieved major medical breakthroughs, including the development of 3D mini-intestines (orga...
Read More →Researchers at Case Western Reserve University have demonstrated that Alzheimer's disease can be reversed to achieve ful...
Read More →The Mayo Clinic's Tapestry study has generated the largest-ever collection of exome data from over 100,000 participants,...
Read More →